2 STIs Flashcards
What are the five P’s of taking a sexual history?
Partners
• Men, women, both
• How many in past year
• Last time you had sex
Practices - sites of exposure
Prevention of pregnancy
Protection from STIs
Past hx of STIs - them and partners
What population accounts for half of all new STIs?
Youth (ages 15-24)
Special populations for STIs
Youth (15-24)
MSM
Pregnant women
HIV-infected patients
Individuals entering correctional facilities
General term for disorders of the vagina caused by infection, inflammation, or changes in the normal vaginal flora
Vaginitis
Sx of vaginitis
Vaginal discharge
Odor
Pruritis and/or discomfort
Most common causes of vaginitis
Candida vulvovaginitis
Bacterial vaginosis
Trichomoniasis
Is vulvovaginal candidiasis considered an STI?
Nope
What is the prevalence of vulvovaginal candidiasis?
Common - exact prevalence difficult to determine
Highest among women in their reproductive years
Causative organism of vulvovaginal candidiasis?
Usually C. albicans
Can be caused by other Candida sp or yeast (ie C. glabrata - resistant to fluconazole)
Clinical presentation of vulvovaginal candidiasis
Sx: PRURITIS, external dysuria, vulvar soreness, dyspareunia, and abnormal vaginal discharge
PE: white, THICK, CURD-LIKE discharge (adherent to vaginal walls)
May see vulvar erythema, edema, fissures, or excoriations
Risk factors for vulvovaginal candidiasis
DM
Abx use
Increased estrogen levels
Immunosuppressed
How is vulvovaginal candidiasis diagnosed?
Clinically
If necessary:
• 10% KOH wet mount - budding yeast, hyphae, or pseudohyphae
• Normal vaginal pH (<4.5)
• MAYBE vaginal culture (not likely to happen)
How do you treat vulvovaginal candidiasis?
Indicated for relief of symptoms
Uncomplicated:
• Short course (1-3 days) of topical azole (ie Clotrimazole) OR
• Oral fluconazole 150mg PO x1
Complicated:
• Longer duration (7-14d) topical azole OR
• Oral fluconazole 150mg q72h x 2-3 doses
• Maintenance rx for recurrent
What makes a case of vulvovaginal candidiasis complicated?
Severe Sx
Recurrent infection
Nonalbicans sp
Pregnancy (use topical azole, not fluconazole)
Poorly controlled DM
Immunosuppression
Do you need to treat partners of patients with vulvovaginal candidiasis?
No data to support tx of partner(s) unless male partner has Sx of balanitis
Is Bacterial Vaginosis considered an STI?
No but sexual activity is a major risk factor
Most common cause of vaginal discharge in women of childbearing age
Bacterial vaginosis
Replacement of “healthy” vaginal flora (Lactobacillus sp) with overgrowth of anaerobic bacteria
Bacterial vaginosis
What is the causative organism(s) of bacterial vaginosis?
Cause is usually polymicrobial (so culture not helpful)
Often associated with Gardnerella vaginalis, Mobiluncus sp., Prevotella sp.
Clinical presentation of bacterial vaginosis
Asymptomatic in 50-75%
Symptomatic: vaginal discharge and/or vaginal odor - THIN, white or gray with STRONG “FISHY SMELL”
Risk factors for bacterial vaginosis
Sexual activity (esp with new or multiple sex partners)
Presence of other STIs
Race/ethnicity (African-Am, Mexican-Am)
Douching (regularly)
Smoking
Lack of condom use
What is Amsel’s Criteria?
Clinical diagnostic criteria for BV
Presence of at least 3….
- Thin, white, homogenous discharge
- CLUE CELLS on SALINE wet mount (vs. KOH for candida)
- Vaginal fluid pH >4.5
- (+) whiff test 🤮🤮🤮
What is a (+) “whiff test”
Presence of a fishy odor when a drop of 10% KOH is added to a sample of vaginal discharge
Indicative of BV
Who should be treated for BV?
Patients with SYMPTOMS - may be identified on Pap smear but only symptomatic patients need meds
Pregnancy if SYMPTOMATIC
Tx of sex partners not recommended
What is the treatment regimen for BV?
Metronidazole 500mg PO BID x 7 days**
or
Metronidazole gel 0.75% intravaginally QD x 5 days
or
Clindamycin cream 2% intravaginally QHS x 7 days
Complications of BV
Increases risk of acquiring and transmitting HIV
Increases risk of acquiring HSV-2, N. gonorrhoeae, C. trachomatis, and T. vaginalis
BV is more common among women with PID (independent risk factor?)
What is the CDC recommendation for women diagnosed with BV?
All women with BV should be offered testing for HIV and other STIs
Most common non viral STI worldwide
Trichomoniasis
Most have minimal or no symptoms (70-85%)
Causative organism for Trichomoniasis
Trichomonas vaginalis
Flagellated protozoan
Coexistence of T. vaginalis and BV pathogens is common
Clinical presentation of trichomoniasis
Asymptomatic in most
Sx:
• Malodorous, FROTHY, YELLOW-GREEN vaginal discharge, +/- vulvar irritation
• Burning, pruritis, dysuria, or dyspareunia
• Postcoital bleeding can occur (b/c of cervical involvment)
PE:
• Punctate hemorrhages on vagina/cervix (STRAWBERRY CERVIX)
•Vaginal pH >4.5
How is trichomoniasis diagnosed?
**Saline wet mount shows MOTILE ORGANISMS (be quick!)
**Nuclei acid amplification test (NAAT) is now the gold standard (highly sensitive and specific)
Culture - may take up to 7 days, not widely available
Rapid antigen and DNA probes ?
Complications of trichomoniasis
If untreated —> urethritis or cystitis
PID (esp if with HIV)
Cervical neoplasia
Infertility
Increased risk of acquiring/transmitting HIV
Complications of trichomoniasis in PREGNANCY
Increased risk of premature rupture of membranes, premature delivery, low birth weight
Treatment of Trichomoniasis
Treat both asymptomatic and symptomatic partners
Metronidazole 2g single dose (safe in pregnancy)
• Avoid alcohol for at least 72 hours
Abstain from sex until patient and partner both treated (wait at least 7 days)
Test for other STIs incl HIV